These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14752221)

  • 1. Identification of colon cancer patients by molecular diagnosis.
    Müller O
    Dig Dis; 2003; 21(4):315-9. PubMed ID: 14752221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for colorectal cancer.
    Kartha CC
    Natl Med J India; 1993; 6(3):134-5. PubMed ID: 8329993
    [No Abstract]   [Full Text] [Related]  

  • 3. Staging of colon and rectal cancer: from endoscopy to molecular markers.
    Greene FL
    Surg Endosc; 2006 Apr; 20 Suppl 2():S475-8. PubMed ID: 16544060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
    Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
    Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
    Sidransky D; Tokino T; Hamilton SR; Kinzler KW; Levin B; Frost P; Vogelstein B
    Science; 1992 Apr; 256(5053):102-5. PubMed ID: 1566048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer survival by location and microsatellite status: data from the Colon Cancer Family Registries and their implications.
    Lynch PM
    Dis Colon Rectum; 2013 Aug; 56(8):935-6. PubMed ID: 23838860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].
    Koornstra JJ; Røkke O; Halvorsen JF; Haug K; Ogreid D
    Tidsskr Nor Laegeforen; 1995 Oct; 115(26):3266-70. PubMed ID: 7482456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood in feces. A screening method for early discovery of colorectal cancer].
    Kewenter J
    Lakartidningen; 1994 Mar; 91(9):803-4. PubMed ID: 8139343
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
    Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
    Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening colorectal cancer: fecal occult blood tests.
    Boone WT
    J Miss State Med Assoc; 1985 Apr; 26(4):95-7. PubMed ID: 3989861
    [No Abstract]   [Full Text] [Related]  

  • 13. The detection of asymptomatic colorectal cancer.
    Miller SF
    Am Fam Physician; 1978 Sep; 18(3):89-92. PubMed ID: 685802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
    Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
    Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers for colorectal cancer screening.
    Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
    Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular screening for colon cancer detection.
    Villa E
    Dig Liver Dis; 2000 Mar; 32(2):173-7. PubMed ID: 10975793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic security of occult blood tests in feces in early diagnosis of colorectal carcinoma in neoplasm screening].
    Heinrich HC
    Dtsch Med Wochenschr; 1979 Oct; 104(42):1496-7. PubMed ID: 498967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Groups at risk and early detection of cancer of the colon and rectum].
    De Llano Rodríguez I; Rodrigo Sáez L; Prados Cano D; Schleiman Halabi H
    Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):414-8. PubMed ID: 2740581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
    Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
    Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.